newsfilter
← Latest News
Business Wire·

Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics

Clinical portfolio, informed by deep and novel synapse biology and pharmacology insights, aims to strengthen neural connections through event-driven pharmacology Lead candidate zelquistinel is currently enrolling